| 英文别名 |
4-Chloro-7H-pyrrolo[2,3-d]pyrimidine;4-Chloro-1H-pyrrolo[2,3-d]pyrimidine;6-Chloro-7-deazapurine;4-Chloro-1H-pyrrolo(2,3-d)pyrimidine;4-Chloro-5H-pyrrolo[2,3-d]pyrimidine;4-chloro-7,7a-dihydro-4aH-pyrrolo[2,3-d]pyrimidine;4-chloro-7H-pyrrolo-(2,3-d)pyrimidine;4-chloro-7H-pyrrolo[2,3-d]-pyrimidine;4-chloropyrrolo[2,3-d]pyrimidine;7H-Pyrrolo[2,3-d]pyrimidine, 4-chloro-;4-Chloropyrrolo(2,3-d)pyrimidine;7H-Pyrrolo(2,3-d)pyrimidine, 4-chloro-;Tofacitinib Impurity 06;1H-Pyrrolo[2,3-d]pyrimidine, 4-chloro-;MLS002693495;BPTCCCTWWAUJRK-UHFFFAOYSA-N;6-Chloro-7-deazapurine (4-Chloro-1h-pyrrolo(2,3-d)pyrimidine);4-Chloro-7H-pyrrolo(;4-chloro-7hpyrrolo[2,3-d]pyrimidine;4chloro-7H-pyrrolo[2,3-d]pyrimidine;PB12763;HY-40351;Q-200553;4-CHLORO-3H-PYRROLO[2,3-D]PYRIMIDINE;DTXSID70190280;4-chloro-pyrrolo[2,3-d]pyrimidine;AKOS005070307;AM946;6-Chloro-7-deazapurine, 97%;CS-B0456;6-Chloro-7-deazapurin;AKOS015966378;4-chloro-7H-pyrrolo[2,3-d]primidine;GS-6804;NSC64952;3Z-0603;SMR001559448;Z857668178;tofacitinib intermediate;3680-69-1;A6334;NCIOpen2_000244;4-Chloro-7H-pyrrolo[2,3-d]pyrimidine;6-Chloro-7-deazapurine;MFCD01686865;SCHEMBL102201;NSC 64952;4-chloro-7H-pyrrolo[2,3-d]pyr-imidine;CHEMBL2133071;4-Chloropyrrolo[2,3-d]pyrimidine;AC-2838;UNII-9VV5MK5RX3;EN300-56508;4-chloro-1H-pyrrolo-[2,3-d]pyrimidine;FT-0601986;9VV5MK5RX3;HMS3085B16;BRN 0607871;BCP01366;AS-31013;C2306;4-Chloro-7H-pyrrolo(2,3-d)pyrimidine;SY003080;F5608-0080;NSC-64952;CL3424;6-chloro-7-deaza purine;4-Chloro-7H-pyrrolo[2,3-d]pyrimidine # |
